EC Number |
Title |
Organism |
---|
2.4.1.122 | C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer |
Homo sapiens |
2.4.1.122 | C1GALT1 seems to promote in vitro disease progression in ovarian cancer |
Homo sapiens |
2.4.1.122 | Glucuronylated core 1 glycans are required for precise localization of neuromuscular junctions and normal formation of basement membranes on Drosophila muscles |
Drosophila melanogaster |
2.4.1.122 | Oocyte-specific ablation of N- and O-glycans alters cumulus cell signalling and extracellular matrix composition |
Mus musculus |
2.4.1.122 | A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-acetyl-galactosamine beta-1,3-galactosyltransferase family |
Homo sapiens |
2.4.1.122 | B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy |
Homo sapiens |
2.4.1.122 | Characterization of mucin-type core-1 beta1-3 galactosyltransferase homologous enzymes in Drosophila melanogaster |
Drosophila melanogaster |
2.4.1.122 | Cloning and expression of human core 1 beta1,3-galactosyltransferase |
Caenorhabditis elegans |
2.4.1.122 | Cloning and expression of human core 1 beta1,3-galactosyltransferase |
Rattus norvegicus |
2.4.1.122 | Cloning and expression of human core 1 beta1,3-galactosyltransferase |
Mus musculus |